English
Advanced Enzyme Technologies Q2 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
284.70
-17.80 (-5.88%)
-17.80 (-5.88%)Volume15.13 K
Updated: Mon 12 Jan, 2026 | 15:29:04
NSE
284.65-18.05 (-5.96%)
-18.05 (-5.96%)Volume4.10 L
Updated: Mon 12 Jan, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹184.53 Cr.(26.31%)
- Operating Profit₹49.98 Cr.(49.10%)
- Profit After Tax₹43.33 Cr.(31.96%)
- Operating Margin27.08%(18.05%)
Note: Comparison is on YoY basis
Quarterly - Advanced Enzyme Technologies Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 134.55 | 139.10 | -3.27% | 112.58 | 19.52% |
| Depreciation/ Amortization | 10.08 | 9.62 | 4.76% | 8.90 | 13.28% |
| Operating Income | 49.98 | 46.81 | 6.76% | 33.52 | 49.10% |
| Net Income | 43.33 | 39.93 | 8.50% | 32.83 | 31.96% |
| Other Operating Expenses Total | 40.53 | 39.72 | 2.05% | 35.46 | 14.30% |
| Net Income Before Taxes | 59.54 | 54.90 | 8.45% | 42.21 | 41.06% |
| Total Revenue | 184.53 | 185.91 | -0.75% | 146.10 | 26.31% |
| Selling/ General/ Admin Expenses Total | 39.37 | 39.71 | -0.86% | 35.52 | 10.84% |
| Diluted Normalized EPS | 3.86 | 3.57 | 8.11% | 2.93 | 31.72% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.